Caption Management’s Kyntra Bio KYNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-3,624
Closed -$80.8K 1389
2024
Q2
$80.8K Buy
+3,624
New +$112K ﹤0.01% 1034
2024
Q1
Sell
-5,048
Closed -$112K 1349
2023
Q4
$112K Hold
5,048
﹤0.01% 1169
2023
Q3
$109K Sell
5,048
-10,140
-67% -$398K ﹤0.01% 1146
2023
Q2
$1.03M Buy
15,188
+874
+6% +$361K 0.02% 656
2023
Q1
$6.68M Sell
14,314
-841
-6% -$445K 0.13% 180
2022
Q4
$6.07M Buy
15,155
+2,155
+17% +$825K 0.09% 260
2022
Q3
$4.23M Hold
13,000
0.06% 395
2022
Q2
$3.43M Buy
+13,000
New +$3.32M 0.05% 488
2021
Q4
Sell
-1,596
Closed -$497K 1701
2021
Q3
$408K Buy
+1,596
New +$566K ﹤0.01% 1243
2020
Q1
Sell
-4,492
Closed -$4.82M 921
2019
Q4
$4.82M Buy
4,492
+2,412
+116% +$2.46M 0.16% 169
2019
Q3
$1.92M Buy
2,080
+376
+22% +$413K 0.1% 246
2019
Q2
$1.92M Buy
1,704
+192
+13% +$210K 0.1% 252
2019
Q1
$2.06M Sell
1,512
-168
-10% -$228K 0.11% 233
2018
Q4
$1.94M Buy
+1,680
New +$1.89M 0.16% 187

Other funds holding KYNB

Caption Management's KYNB Position: Q3 2024 in Review

Caption Management sold out of Kyntra Bio (KYNB) in Q3 2024, closing a stake of 3,624 shares — an estimated $80.8K sold.

Caption Management first reported a position in KYNB in Q4 2018 and held it in 14 quarters. The position peaked at $6.68M in Q1 2023. 70 funds tracked by Wall St. Rank hold KYNB as of Q3 2024.

  • Caption Management reported no remaining Kyntra Bio position as of Q3 2024 after selling out during the quarter.
  • Caption Management sold 3,624 Kyntra Bio shares in Q3 2024, an estimated $80.8K.
  • Caption Management first reported a position in Kyntra Bio in Q4 2018 and held it in 14 quarters.
  • Caption Management's Kyntra Bio position peaked at $6.68M in Q1 2023.
  • 70 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2024.

Based on Caption Management's 13F filing for Q3 2024, filed 14 Nov 2024.